Proportion of Alzheimer Patients Treated With Cholinesterase-Inhibitors or Memantine
Identifying Attributes
Care Settings
Dementia Care
Country
Sweden
Publishing Organisation
Swedish Dementia Registry (SveDem)
Type of Quality Indicator
Process
IOM Quality Dimension
Effectiveness
Setting-Specific Domain
Interventions to Promote Cognition, Independence and Wellbeing
Defining Attributes
Definition
Proportion of Alzheimer patients treated with cholinesterase-inhibitors or memantine
Numerator
Number of Alzheimer patients treated with cholinesterase-inhibitors or memantine
Denominator
Exclusions
Use of Risk Adjustment
No
Risk Adjustments
None
Stratifications
None
Collection and Reporting Attributes
Type of Data Collection
Data Collection Methods
Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
No
Source and Reference Attributes
Evidence Source
Religa, D. et al. Svedem, the Swedish dementia registry – A tool for improving the quality of diagnostics, treatment and care of dementia patients in clinical practice. PLOS ONE 10, e0116538 (2015).
Technical Specifications
Link to Measurement Tools
Domain
Not Assigned
Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
No
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
No
Australian Consortium for Aged Care Endorsed
No
Can the Quality Indicator be Readily Implemented at a Population Level in Australia Given its Current Data Landscape?
Implementation of this quality indicator was not assessed.
Identified by PHARMA-Care Project
Yes
Upload Date
23 July 2025
Contents
Actions
Date Modified 11 June 2026